These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24399354)

  • 21. Molecular epidemiology and susceptibility profiles of Clostridium difficile in New Zealand, 2009.
    Roberts S; Heffernan H; Al Anbuky N; Pope C; Paviour S; Camp T; Swager T
    N Z Med J; 2011 Apr; 124(1332):45-51. PubMed ID: 21747423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An information campaign on aminoglycosides use during septic shock failed to improve the quality of care.
    Fischer MO; Parienti JJ; Daurel C; Debruyne D; Verdon R; Gérard JL; Hanouz JL; Fellahi JL
    Ann Fr Anesth Reanim; 2012 Jan; 31(1):e1-5. PubMed ID: 22154443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology, diagnosis and treatment of Clostridium difficile infection.
    Bassetti M; Villa G; Pecori D; Arzese A; Wilcox M
    Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1405-23. PubMed ID: 23253319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimer resurrects C. difficile antibiotic to win approval.
    Fox JL
    Nat Biotechnol; 2011 Jul; 29(7):557-8. PubMed ID: 21747365
    [No Abstract]   [Full Text] [Related]  

  • 26. Fidaxomicin: a novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection.
    Venugopal AA; Johnson S
    Clin Infect Dis; 2012 Feb; 54(4):568-74. PubMed ID: 22156854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clostridium difficile diarrhea.
    Williams CN
    Can J Gastroenterol; 1999 May; 13(4):293-4. PubMed ID: 10360986
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prevention and therapy of infections in intensive internal medicine].
    Vogel F
    Fortschr Med; 1983 Apr; 101(16):749, 752, 754-5 passim. PubMed ID: 6852751
    [No Abstract]   [Full Text] [Related]  

  • 29. Epidemiological features of Clostridium difficile infection among inpatients at Hamad General Hospital in the state of Qatar, 2006-2009.
    Khan FY; Abu-Khattab M; Anand D; Baager K; Alaini A; Siddique MA; Mohamed SF; Ali MI; Al Bedawi MM; Naser MS
    Travel Med Infect Dis; 2012 Jul; 10(4):179-85. PubMed ID: 22800937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium difficile colitis: epidemiology, pathophysiology, and treatment.
    Mitty RD; Lamont JT
    Mt Sinai J Med; 1994 Sep; 61(4):329-35. PubMed ID: 7969226
    [No Abstract]   [Full Text] [Related]  

  • 31. Clostridium difficile infection in the intensive care unit.
    Leclair MA; Allard C; Lesur O; Pépin J
    J Intensive Care Med; 2010; 25(1):23-30. PubMed ID: 20034951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fidaxomicin approved for C. difficile infections.
    Traynor K
    Am J Health Syst Pharm; 2011 Jul; 68(14):1276. PubMed ID: 21719581
    [No Abstract]   [Full Text] [Related]  

  • 33. Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients.
    Chopra T; Alangaden GJ; Chandrasekar P
    Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1113-9. PubMed ID: 20954878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection?
    Kuijper EJ; Wilcox MH
    Clin Infect Dis; 2008 Jul; 47(1):63-5. PubMed ID: 18491959
    [No Abstract]   [Full Text] [Related]  

  • 35. The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection.
    Bartlett JG
    Clin Infect Dis; 2008 May; 46(10):1489-92. PubMed ID: 18419480
    [No Abstract]   [Full Text] [Related]  

  • 36. Basic and clinical aspects of Clostridium difficile colitis.
    Morishita T; Nakayama T; Kamiya T; Mori S; Isobe K; Furuta Y
    Rev Gastroenterol Peru; 2004; 24(3):263-9. PubMed ID: 15483687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fidaxomicin: a minimally absorbed macrocyclic antibiotic for the treatment of Clostridium difficile infections.
    Soriano MM; Liao S; Danziger LH
    Expert Rev Anti Infect Ther; 2013 Aug; 11(8):767-76. PubMed ID: 23977933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clostridium difficile infection in the elderly.
    Taslim H
    Acta Med Indones; 2009 Jul; 41(3):148-51. PubMed ID: 19752488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.
    Citron DM; Babakhani F; Goldstein EJ; Nagaro K; Sambol S; Sears P; Shue YK; Gerding DN
    Anaerobe; 2009 Dec; 15(6):234-6. PubMed ID: 19755166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Clostridium difficile-associated disease.
    Leffler DA; Lamont JT
    Gastroenterology; 2009 May; 136(6):1899-912. PubMed ID: 19457418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.